Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Achillion Appoints CSO

This article was originally published in Scrip

Executive Summary

Achillion Pharmaceuticals has appointed Joel Barrish chief scientific officer and executive vice president – effective Jan. 4, 2016. Barrish has over 30 years' experience in the pharmaceutical industry and most recently was vice president and head of discovery chemistry at Bristol-Myers Squibb (BMS). He has also co-authored more than 120 peer-reviewed publications.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

SC064120

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel